4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Arthritis, Rheumatoid in 1 studies
4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.
Arthritis, Rheumatoid: A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Snir, O | 1 |
Hesselberg, E | 1 |
Amoudruz, P | 1 |
Klareskog, L | 1 |
Zarea-Ganji, I | 1 |
Catrina, AI | 1 |
Padyukov, L | 1 |
Malmström, V | 1 |
Seddighzadeh, M | 1 |
1 other study available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Arthritis, Rheumatoid
Article | Year |
---|---|
Genetic variation in the serotonin receptor gene affects immune responses in rheumatoid arthritis.
Topics: Adult; Aged; Aged, 80 and over; Amphetamines; Arthritis, Rheumatoid; Enterotoxins; Genetic Variation | 2013 |